標(biāo)題: Titlebook: Male Hypogonadism; Basic, Clinical and Stephen J. Winters,Ilpo T. Huhtaniemi Book 2017Latest edition The Editor(s) (if applicable) and The [打印本頁] 作者: 候選人名單 時(shí)間: 2025-3-21 16:28
書目名稱Male Hypogonadism影響因子(影響力)
書目名稱Male Hypogonadism影響因子(影響力)學(xué)科排名
書目名稱Male Hypogonadism網(wǎng)絡(luò)公開度
書目名稱Male Hypogonadism網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Male Hypogonadism被引頻次
書目名稱Male Hypogonadism被引頻次學(xué)科排名
書目名稱Male Hypogonadism年度引用
書目名稱Male Hypogonadism年度引用學(xué)科排名
書目名稱Male Hypogonadism讀者反饋
書目名稱Male Hypogonadism讀者反饋學(xué)科排名
作者: innovation 時(shí)間: 2025-3-21 22:13 作者: Polydipsia 時(shí)間: 2025-3-22 03:31 作者: 炸壞 時(shí)間: 2025-3-22 07:19
Normal and Delayed Puberty, by the activation of the hypothalamic–pituitary–gonadal axis after the break that restrains this axis during the majority of childhood is released. This review will cover the clinical assessment of puberty, variation in the timing of puberty, and the complex factors that regulate the onset and timi作者: 刪除 時(shí)間: 2025-3-22 10:33 作者: GLOOM 時(shí)間: 2025-3-22 12:58
Male Hypogonadism Resulting from Mutations in the Genes for the Gonadotropin Subunits and Their Recm. No germ line mutations of CGA have been reported, apparently because of the incompatibility of pregnancy maintenance in the absence of hGG. Five inactivating LHB mutations have been described in men with normal prenatal masculinization but arrested pubertal development. The three men so far descr作者: Infuriate 時(shí)間: 2025-3-22 19:49
Hypogonadism in Males with Congenital Adrenal Hyperplasia,quent cause of impaired fertility. Their location adjacent to the testicular mediastinum, and their steroid-producing properties, may interfere with spermatogenesis and Leydig cell function. It is sometimes accompanied by hypergonadotropic hypogonadism. Hypogonadotropic hypogonadotropism is a second作者: Synchronism 時(shí)間: 2025-3-22 21:48 作者: 格言 時(shí)間: 2025-3-23 02:32
Klinefelter Syndrome and Other Forms of Primary Testicular Failure, least one supernumerary X chromosome resulting in a 47, XXY genotype. KS can present in childhood, adolescence or adulthood with varying degrees of hypogonadism, gynecomastia, very small testes and azoospermia. In adults, FSH and LH levels are elevated, and testosterone levels are low or low normal作者: 不要嚴(yán)酷 時(shí)間: 2025-3-23 06:45 作者: 尊敬 時(shí)間: 2025-3-23 12:19 作者: pancreas 時(shí)間: 2025-3-23 15:43 作者: STELL 時(shí)間: 2025-3-23 19:37
Exercise and Male Hypogonadism: Testosterone, the Hypothalamic-Pituitary-Testicular Axis, and Exerc exercise training, testosterone will acutely increase, decrease or have no change in concentration, depending on many factors including exercise modality, intensity, and duration. Exercise training places a tremendous amount of stress on the body, and if excessive or not managed appropriately, it c作者: 感情脆弱 時(shí)間: 2025-3-24 01:08
Environmental Causes of Testicular Dysfunction, (smoking, alcohol, sedentation, recreational drugs, pharmaceutical drugs) or chemical exposures (e.g., pesticides and other endocrine-disrupting compounds). Such factors may cause their impact via effects during fetal development (i.e., maternal pregnancy effects) or in adulthood, or via a combinat作者: 檔案 時(shí)間: 2025-3-24 03:41
Sex Hormone-Binding Globulin and the Metabolic Syndrome,phic balance between circulating testosterone and estradiol levels. In men, low testosterone levels are a major risk factor for the MetS, and testosterone replacement therapy has been proposed as treatment option for associated conditions, i.e., type 2 diabetes and cardiovascular disease. The plasma作者: 山頂可休息 時(shí)間: 2025-3-24 07:15
An Ensemble Perspective of Aging-Related Hypoandrogenemia in Men,y weight, nutrition, and the presence of diabetes mellitus. The 0.8–1.3% annual fall in nonSHBG bound “bioavailable” testosterone levels results in a reduction of 30–50% by the sixth to eighth decades of life. Low testosterone concentrations are associated with relative sarcopenia, osteopenia, visce作者: HEDGE 時(shí)間: 2025-3-24 12:59
Obesity and Aging in Late-Onset Hypogonadism,pituitary function which are aggravated by changes due to aging-related chronic illnesses. Obesity, independent of age, is also associated with low T from low SHBG and down-regulation of hypothalamic–pituitary gonadotropin secretion, the mechanisms for which may involve adipokines, pro-inflammatory 作者: 值得尊敬 時(shí)間: 2025-3-24 16:19 作者: BUCK 時(shí)間: 2025-3-24 20:33
Androgen Therapy for Hypogonadism in Men with Chronic Illnesses,gy, and poor sleep in conjunction with observable sarcopenia and osteopenia, are prominent in many of these chronic disorders, and are reminiscent of symptomatic hypogonadism. Unequivocally androgen-responsive organs include bone, striated muscle, cardiac muscle, vascular smooth muscle, brain and ad作者: 亂砍 時(shí)間: 2025-3-25 00:19 作者: ALIAS 時(shí)間: 2025-3-25 06:45 作者: Incommensurate 時(shí)間: 2025-3-25 09:46
Contemporary Endocrinologyhttp://image.papertrans.cn/m/image/621916.jpg作者: Osteons 時(shí)間: 2025-3-25 12:03
978-3-319-85119-8The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: 符合國(guó)情 時(shí)間: 2025-3-25 18:11
Male Hypogonadism978-3-319-53298-1Series ISSN 2523-3785 Series E-ISSN 2523-3793 作者: excursion 時(shí)間: 2025-3-25 22:43
Neuroendocrine Control of Human Testicular Function,roper set-point by the negative feedback effects of testicular steroids and inhibin-B. Testicular function is also influenced by multiple internal (paracrine and autocrine) and external (endocrine) environmental factors.作者: TRUST 時(shí)間: 2025-3-26 01:43 作者: Tartar 時(shí)間: 2025-3-26 04:53 作者: Formidable 時(shí)間: 2025-3-26 11:29
Androgen Replacement Therapy in Hypogonadal Men,gen receptor modulators may have the potential of optimizing beneficial effects while minimizing potential adverse effects. In older men, monitoring of prostate dysfunction and red cell indexes is necessary and important. With care, androgens can be used efficaciously and with minimal potential side effects.作者: 起皺紋 時(shí)間: 2025-3-26 15:18
Androgen Therapy for Hypogonadism in Men with Chronic Illnesses,dysfunction of these organs. However randomized placebo-controlled trials are still required to establish efficacy. This chapter summarizes and tabulates these pivotal randomized placebo-controlled studies, and makes recommendations regarding potential uses and further research.作者: 潛移默化 時(shí)間: 2025-3-26 18:05 作者: PRE 時(shí)間: 2025-3-26 21:40 作者: mitral-valve 時(shí)間: 2025-3-27 03:06 作者: NOCT 時(shí)間: 2025-3-27 06:49
Male Hypogonadism Due to Cancer and Cancer Treatments, resulting in impaired testosterone production. This chapter describes the effects of cancer and its treatment on male reproductive function in terms of damage to the seminiferous epithelium and testosterone production. We also discuss the options, both established and experimental, for fertility preservation in these patients.作者: Melanoma 時(shí)間: 2025-3-27 12:04
The Human Leydig Cell,e fetal Leydig cell population persists into adulthood in mice but becomes secondary to the adult population. Development of the adult Leydig cell population is dependent on the Sertoli cells and on luteinizing hormone (LH) from the pituitary. The adult cells in humans secrete mainly testosterone sy作者: 熒光 時(shí)間: 2025-3-27 15:06
Normal and Delayed Puberty,on or short courses of low-dose sex steroid supplementation. More complex and involved management is required in males with hypogonadism to achieve both the development of secondary sexual characteristics and to maximize the potential for fertility.作者: antiquated 時(shí)間: 2025-3-27 21:05
Congenital Hypogonadotropic Hypogonadism in Males: Clinical Features and Pathophysiology,iderable phenotypic heterogeneity in the clinical presentation of CHH, and, in addition to the typical KS and nCHH presentations, several variant forms of CHH are recognized including fertile eunuch variant, adult-onset CHH, and, more recently, reversible forms of CHH, wherein CHH recovers in adulth作者: Obverse 時(shí)間: 2025-3-28 01:29 作者: Commemorate 時(shí)間: 2025-3-28 02:46 作者: exhibit 時(shí)間: 2025-3-28 07:35 作者: 凝乳 時(shí)間: 2025-3-28 12:58
Male Hypogonadism and Liver Disease,n the majority of individuals. However, this finding is not uniform, likely related in part to pre-existing metabolic damage, immunosuppression, graft function, and potentially other comorbidities. Further research is needed on the efficacy and safety of testosterone treatment in liver disease.作者: hematuria 時(shí)間: 2025-3-28 18:23 作者: Migratory 時(shí)間: 2025-3-28 22:47
Environmental Causes of Testicular Dysfunction,ct is equivocal, and it is argued that dietary and lifestyle changes are more likely to be important. There are considerable difficulties in studying how environmental effects can impact male reproductive health, especially where fetal origins are suspected, but readers are reminded to remain open t作者: 感染 時(shí)間: 2025-3-29 02:01 作者: Fluctuate 時(shí)間: 2025-3-29 03:25 作者: epidermis 時(shí)間: 2025-3-29 09:33 作者: 凹室 時(shí)間: 2025-3-29 12:57
Book 2017Latest editioned to current approaches to stimulating spermatogenesis in gonadotropin-deficient men.?.Highly practical and updated with the latest available data, this second edition of?.Male Hypogonadism: Basic, Clinical and Therapeutic Principles?.cogently presents a large body of scientific information on male作者: Insul島 時(shí)間: 2025-3-29 17:42
2523-3785 ghly practical and updated with the latest available data, this second edition of?.Male Hypogonadism: Basic, Clinical and Therapeutic Principles?.cogently presents a large body of scientific information on male978-3-319-85119-8978-3-319-53298-1Series ISSN 2523-3785 Series E-ISSN 2523-3793 作者: perpetual 時(shí)間: 2025-3-29 21:53
Haiqi Chen PhD,Dolores Mruk PhD,Xiang Xiao PhD,C. Yan Cheng PhD作者: 六個(gè)才偏離 時(shí)間: 2025-3-30 01:00 作者: otic-capsule 時(shí)間: 2025-3-30 04:29
Nike M. M. L. Stikkelbroeck MD, PhD,Hedi L. Claahsen-van der Grinten MD, PhD作者: vitreous-humor 時(shí)間: 2025-3-30 08:24
Rosario Pivonello MD, PhD,Ciro Salzano MD,Mariano Galdiero MD,Annamaria Colao MD, PhD作者: strain 時(shí)間: 2025-3-30 15:48
Peter A. Lee MD, PhD,Christopher P. Houk MD,Jorma Toppari MD, PhD作者: subordinate 時(shí)間: 2025-3-30 20:29
Samuel M. Kim MD,Swaytha Yalamanchi MD,Adrian S. Dobs MD作者: 可行 時(shí)間: 2025-3-30 20:51
Rod T. Mitchell BSc, MBChB, PhD,Jan-Bernd Stukenborg MSc, PhD,Kirsi Jahnukainen MD, PhD作者: 溺愛 時(shí)間: 2025-3-31 02:28
Anthony C. Hackney PhD, DSc,Travis Anderson MA,Jennifer Dobridge MA作者: insurgent 時(shí)間: 2025-3-31 06:15 作者: 使隔離 時(shí)間: 2025-3-31 10:24
Jonas ?eponis MD, PhD,Ronald S. Swerdloff MD,Christina Wang MD作者: Intentional 時(shí)間: 2025-3-31 17:02
Wenyi Zhang MD,Moizza Shabbir BA,Peter Y. Liu MBBS, PhD, FRACP作者: CROAK 時(shí)間: 2025-3-31 20:29
9樓作者: neolith 時(shí)間: 2025-4-1 00:24
9樓作者: eucalyptus 時(shí)間: 2025-4-1 04:52
10樓作者: alabaster 時(shí)間: 2025-4-1 09:22
10樓作者: assail 時(shí)間: 2025-4-1 12:02
10樓作者: compel 時(shí)間: 2025-4-1 16:29
10樓
